These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 5784646)
21. On the mechanism of amphetamine potentiation by iprindole. Miller KW; Freeman JJ; Dingell JV; Sulser F Experientia; 1970 Aug; 26(8):863-4. PubMed ID: 5452016 [No Abstract] [Full Text] [Related]
22. A new design for the screening of CNS-active drugs in mice. A multi-dimensional observation procedure and the study of pharmacological interactions. Morpurgo C Arzneimittelforschung; 1971 Nov; 21(11):1727-34. PubMed ID: 5172082 [No Abstract] [Full Text] [Related]
23. A rational framework for the development, evaluation, and use of psychoactive drugs. Irwin S Am J Psychiatry; 1968 Feb; 124(8):Suppl:1-19. PubMed ID: 4865729 [No Abstract] [Full Text] [Related]
25. [Psychodrugs in anesthesiology]. Frosali L; Salvini L Acta Anaesthesiol; 1967; 18(5):649-745. PubMed ID: 4890106 [No Abstract] [Full Text] [Related]
26. The effect of psychotropic drugs on food reinforced behavior and on food consumption. Bainbridge JG Psychopharmacologia; 1968; 12(3):204-13. PubMed ID: 5747770 [No Abstract] [Full Text] [Related]
27. A direct effect of dibutyryl cyclic AMP on the duration of narcosis induced by sedative, hypnotic, tranquiliser and anaesthetic drugs in the rat. Cohn ML; Cohn M; Taylor FH; Scattaregia F Neuropharmacology; 1975 Jul; 14(7):483-7. PubMed ID: 168513 [No Abstract] [Full Text] [Related]
28. Drug-induced modifications of discriminated avoidance behavior in rats. Morpurgo C Psychopharmacologia; 1965 Jul; 8(2):91-9. PubMed ID: 4379108 [No Abstract] [Full Text] [Related]
29. [Classification of the psychopharmacodynamic effects on personality and psychopathological syndromes]. Barahona Fernandes Encephale; 1965; 54(2):155-73. PubMed ID: 4378690 [No Abstract] [Full Text] [Related]
30. The uses and relative hazard potential of psychoactive drugs. Irwin S Bull Menninger Clin; 1974 Jan; 38(1):14-48. PubMed ID: 4149474 [No Abstract] [Full Text] [Related]
31. Potentiation of barbital sodium hypnosis as a screening method for central nervous system depressants. Sethy VH; Mandrekar SS; Sheth UK Indian J Med Sci; 1967 Jan; 21(1):32-7. PubMed ID: 6035617 [No Abstract] [Full Text] [Related]
33. The effect of certain tranquilisers, chlorpromazine metabolites and diethyldithiocarbamate on tissue amphetamine levels in the rat. Lal S; Sourkes TL; Missala K Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):122-30. PubMed ID: 4151045 [No Abstract] [Full Text] [Related]
34. [On the hypothermic effect of some pharmacological agents]. Uriupov OIu Farmakol Toksikol; 1968; 31(5):568-71. PubMed ID: 5707726 [No Abstract] [Full Text] [Related]
36. [Interactions and incompatibilities of drugs acting upon the central nervous system]. Estler CJ Fortschr Med; 1973 Apr; 91(12):513-6. PubMed ID: 4702398 [No Abstract] [Full Text] [Related]
37. Indomethacin potentiates the operant behavior suppressant and rectal temperature lowering effects of low doses of d-amphetamine in rats. Nielsen JA; Sparber SB Pharmacol Biochem Behav; 1984 Aug; 21(2):219-24. PubMed ID: 6483934 [TBL] [Abstract][Full Text] [Related]
38. [Pharmacology of the limbic system. Action of psychotropic drugs]. Psatta D Stud Cercet Neurol; 1969; 14(1):3-34. PubMed ID: 4901803 [No Abstract] [Full Text] [Related]
39. [Characteristics of spectrum of pharmacological activity of hyndarine (1-tetrahydropalmatine) and its effect on the metaboli of catecholamines]. Berezhinskaia VV; Trutneva EA Farmakol Toksikol; 1966; 29(6):731-4. PubMed ID: 6000372 [No Abstract] [Full Text] [Related]
40. Pharmacokinetics and psychopharmacological research. The significance of pharmacokinetic basic data for research of psychopharmaca on human behaviour. van Rossum JM Psychiatr Neurol Neurochir; 1973; 76(3):217-28. PubMed ID: 4725793 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]